RxDoctor Payments Data

Jacob Bernstein

Neurological Surgery · Greeley, CONPI 1023402211

Payments from drug & device makers

What this record shows

This record is dominated by grants: $35,000 of the $35,776 with a category attached, or 97.8%. 10 manufacturers reported payments, led by Medtronic at 56.1% of the total. Reporting peaked in 2022 at $35,064 and has fallen 99.3% since, to $250 in 2025.

$35,776in general payments, 2019–2025

Across 18 payments — averaging $1987.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$20K
  • Boston Scientific$15K
  • Stryker$135
  • Icotec Medical Inc.$130
  • Johnson & Johnson$106
  • Orthofix Medical, Inc.$100
  • plus $163 from 4 others

What the payments were for

  • Grants$35,00098%
  • Food & beverage$7762%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic2$20,070
Boston Scientific2$15,072
Stryker3$135
Icotec Medical Inc.2$130
Johnson & Johnson2$106
Orthofix Medical, Inc.2$100
Neuropace, Inc.1$64
Elevation Spine, Inc.2$45
Si-bone, Inc.1$31
Baxter Healthcare1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,776 in reported general payments places this provider in the 75th percentile of 149 neurological surgery providers in Colorado.

See all neurological surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$78,591
Medicare patients
112
Services billed
240

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin14$209
Methocarbamol18$147
Oxycodone Hcl13$92

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Greeley

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →